PLCD1 and cancer: Importantly, the loss of the GTP-binding, but not transamidating, activity of Gαh was shown to inhibit cancer metastasis in malignant tumor cells [17], implying the critical importance of Gαh/PLC-δ1-dependent signaling in cancer progression.